Find uplifting stories about heroes, innovations, and solutions
1439 results for "hiv vaccine"
After 14 years of research, San Diego scientists developed an HIV vaccine that successfully triggered virus-fighting antibodies in nearly half of the primates tested. The breakthrough could lead to the first effective HIV vaccine for humans within years.
Scientists achieved something that's never happened before: an HIV vaccine that starts working after just one dose. The breakthrough could transform how we fight a virus that's challenged researchers for decades.
Scientists at La Jolla Institute and Scripps Research have created an HIV vaccine that triggered the strongest antibody response ever seen in primates. Human trials are now underway for a vaccine 14 years in the making.
Scientists have developed an HIV vaccine that achieved the strongest antibody response ever recorded in primates, and human trials are already underway. The breakthrough teaches the immune system to produce rare "broadly neutralizing" antibodies that can fight multiple HIV strains.
%2Ffile%2Fattachments%2Forphans%2F2HIVVaccineResearch_437240.jpg)
When the US pulled funding for a groundbreaking HIV vaccine trial in Cape Town, South African scientists refused to quit. They found new backers and launched a scaled-down version that could reinvigorate global vaccine research.
A groundbreaking HIV vaccine study in Cape Town is moving forward after South African researchers regrouped when US funding vanished. The trial tests a novel approach that could finally unlock the key to preventing HIV.
Scientists in Philadelphia created an HIV vaccine that triggered protective antibodies after just one shot in monkeys. The breakthrough could replace current experimental protocols requiring up to ten injections.
South Africa just enrolled its first participant in a groundbreaking HIV vaccine trial designed specifically for African strains of the virus. This time, African scientists are leading the charge.
After 14 years of research, scientists achieved the strongest HIV-neutralizing antibody responses ever seen in primates, bringing hope for an effective vaccine. The breakthrough could finally give the immune system tools to fight a virus that has evaded prevention efforts for decades.
Scientists at MIT and Scripps Research just made a breakthrough that could finally lead to an effective HIV vaccine. Their DNA-based approach generated eight times more of the rare immune cells needed to fight the virus compared to current leading candidates.
A landmark study shows South Africa's free school vaccination program slashed HPV infections by 83%, proving the vaccine works even in regions with high HIV rates. For the first time, researchers confirmed that early vaccination protects girls living with HIV just as well as those without it.
Bertrand Nelson made medical history as the first person with HIV to receive a lung transplant from an HIV-positive donor, opening new possibilities for thousands awaiting organs. His successful surgery marks a turning point in how we treat people living with HIV who face end-stage organ disease.
%2Ffile%2Fattachments%2Forphans%2FProfessorWillemHanekom_276321.jpeg)
Professor Willem Hanekom is co-leading a 20,000-person global trial for the world's most promising TB vaccine while directing Africa's largest health research institute. Living openly with HIV for 19 years, he's dedicated his career to bringing life-saving treatments to underresourced communities.
In 2025, the world achieved stunning health victories as vaccines prevented millions of deaths and ten countries eliminated deadly diseases like malaria, HIV transmission, and sleeping sickness. From the Maldives becoming the first nation to eliminate three diseases at once to new breakthroughs in HIV prevention, science and global cooperation delivered hope.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
Researchers created a breakthrough nanodisc system that shows viruses in their true form, revealing hidden weak points that could lead to more effective vaccines. The technology speeds up vaccine development from months to just one week.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
South Africa is preparing to roll out a groundbreaking tuberculosis vaccine for adults that could become the first new TB vaccine in over a century. The M72/AS01E vaccine is currently in Phase 3 trials across five countries and could help eliminate TB as a public health threat by 2030.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
Showing 20 of 1439